Spyre Therapeutics, Inc.
USD73.52
+4.36 (+6.30%)
CEO
Cameron Turtle
IPO Date
2016-04-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$70.05
Prev. Close
$69.16
Day Low
$69.81
Day High
$76.11
52W Low
$13.93
52W High
$78.80
Market Cap
$4.44B
Volume
1.58M
| 8,026 |
| $72.51 |
| 29 May 2026 | HENDERSON MICHAEL THOMAS | director | A-Award | Acquired | 8,026 | $72.51 |
| 29 May 2026 | Stelzer Laurie | director | A-Award | Acquired | 8,026 | $72.51 |
| 29 May 2026 | McKenna Mark C. | director | A-Award | Acquired | 8,026 | $72.51 |
| 29 May 2026 | Milligan Sandra | director | A-Award | Acquired | 8,026 | $72.51 |
| 8 May 2026 | HENDERSON MICHAEL THOMAS | director | S-Sale | Disposed | 2,404 | $72.57 |
| 8 May 2026 | HENDERSON MICHAEL THOMAS | director | S-Sale | Disposed | 33,513 | $73.72 |
| 8 May 2026 | HENDERSON MICHAEL THOMAS | director | S-Sale | Disposed | 24,814 | $74.76 |
| 8 May 2026 | HENDERSON MICHAEL THOMAS | director | S-Sale | Disposed | 19,269 | $75.35 |